MAIA Biotechnology Inc (AMEX:MAIA) price closed higher on Monday, March 25, jumping 20.85% above its previous close.
A look at the daily price movement shows that the last close reads $2.11. Taking into account the 52-week price action we note that the stock hit a 52-week high of $4.25 and 52-week low of $0.82. The stock added 84.78% on its value in the past month.
MAIA Biotechnology Inc, which has a market valuation of $43.32 million. Analysts tracking MAIA have forecast the quarterly EPS to shrink by -0.39 per share this quarter, while the same analysts predict the annual EPS to hit -$1.58 for the year 2024 and up to $0 for 2025.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give MAIA a short term outlook of 50% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a Hold, while an average of long term indicators are currently assigning the stock as 50% Buy.
The overview shows that MAIA’s price is at present 72.98% off the SMA20 and 76.35% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 83.80, with weekly volatility standing at 25.82%. The indicator jumps to 13.12% when calculated based on the past 30 days. MAIA Biotechnology Inc (AMEX:MAIA)’s beta value is holding at 0.37, while the average true range (ATR) indicator is currently reading 0.24.
An analysis of the MAIA Biotechnology Inc (AMEX:MAIA) stock in terms of its daily trading volume indicates that the 3-month average is 365.09K. However, this figure increases on the past 10-day timeline to an average of 0.36 million.
Current records show that the company has 16.99M in outstanding shares. The insiders’ percentage holdings are 29.19% of outstanding shares while the percentage share held by institutions stands at 4.73%. The stats also highlight that short interest as of Feb 29, 2024, stood at 0.39 million shares, which puts the short ratio at the time at 2.38. From this we can glean that short interest is 2.29% of company’s current outstanding shares. Notably, we see that shares short in February rose slightly given the previous month’s figure stood at 0.39 million. But the 117.95% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
